176 related articles for article (PubMed ID: 15070918)
1. Italian addison network study: update of diagnostic criteria for the etiological classification of primary adrenal insufficiency.
Falorni A; Laureti S; De Bellis A; Zanchetta R; Tiberti C; Arnaldi G; Bini V; Beck-Peccoz P; Bizzarro A; Dotta F; Mantero F; Bellastella A; Betterle C; Santeusanio F;
J Clin Endocrinol Metab; 2004 Apr; 89(4):1598-604. PubMed ID: 15070918
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies against recombinant human steroidogenic enzymes 21-hydroxylase, side-chain cleavage and 17alpha-hydroxylase in Addison's disease and autoimmune polyendocrine syndrome type III.
de Carmo Silva R; Kater CE; Dib SA; Laureti S; Forini F; Cosentino A; Falorni A
Eur J Endocrinol; 2000 Feb; 142(2):187-94. PubMed ID: 10664529
[TBL] [Abstract][Full Text] [Related]
3. Adrenal-cortex autoantibodies and steroid-producing cells autoantibodies in patients with Addison's disease: comparison of immunofluorescence and immunoprecipitation assays.
Betterle C; Volpato M; Pedini B; Chen S; Smith BR; Furmaniak J
J Clin Endocrinol Metab; 1999 Feb; 84(2):618-22. PubMed ID: 10022426
[TBL] [Abstract][Full Text] [Related]
4. Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison's disease.
Laureti S; De Bellis A; Muccitelli VI; Calcinaro F; Bizzarro A; Rossi R; Bellastella A; Santeusanio F; Falorni A
J Clin Endocrinol Metab; 1998 Oct; 83(10):3507-11. PubMed ID: 9768655
[TBL] [Abstract][Full Text] [Related]
5. II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease.
Betterle C; Volpato M; Rees Smith B; Furmaniak J; Chen S; Zanchetta R; Greggio NA; Pedini B; Boscaro M; Presotto F
J Clin Endocrinol Metab; 1997 Mar; 82(3):939-42. PubMed ID: 9062510
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to adrenal cytochrome P450 antigens in isolated Addison's disease and autoimmune polyendocrine syndrome type II.
Seissler J; Schott M; Steinbrenner H; Peterson P; Scherbaum WA
Exp Clin Endocrinol Diabetes; 1999; 107(3):208-13. PubMed ID: 10376448
[TBL] [Abstract][Full Text] [Related]
7. I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: markers of low progression to clinical Addison's disease.
Betterle C; Volpato M; Rees Smith B; Furmaniak J; Chen S; Greggio NA; Sanzari M; Tedesco F; Pedini B; Boscaro M; Presotto F
J Clin Endocrinol Metab; 1997 Mar; 82(3):932-8. PubMed ID: 9062509
[TBL] [Abstract][Full Text] [Related]
8. Low dose (1 microg) ACTH test in the evaluation of adrenal dysfunction in pre-clinical Addison's disease.
Laureti S; Arvat E; Candeloro P; Di Vito L; Ghigo E; Santeusanio F; Falorni A
Clin Endocrinol (Oxf); 2000 Jul; 53(1):107-15. PubMed ID: 10931087
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease, and premature ovarian failure.
Chen S; Sawicka J; Betterle C; Powell M; Prentice L; Volpato M; Rees Smith B; Furmaniak J
J Clin Endocrinol Metab; 1996 May; 81(5):1871-6. PubMed ID: 8626850
[TBL] [Abstract][Full Text] [Related]
10. 21-hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease. Belgian Diabetes Registry.
Falorni A; Laureti S; Nikoshkov A; Picchio ML; Hallengren B; Vandewalle CL; Gorus FK; Tortoioli C; Luthman H; Brunetti P; Santeusanio F
Clin Exp Immunol; 1997 Feb; 107(2):341-6. PubMed ID: 9030873
[TBL] [Abstract][Full Text] [Related]
11. Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency.
Husebye ES; Allolio B; Arlt W; Badenhoop K; Bensing S; Betterle C; Falorni A; Gan EH; Hulting AL; Kasperlik-Zaluska A; Kämpe O; Løvås K; Meyer G; Pearce SH
J Intern Med; 2014 Feb; 275(2):104-15. PubMed ID: 24330030
[TBL] [Abstract][Full Text] [Related]
12. Autoantibody responses in autoimmune ovarian insufficiency and in Addison's disease are IgG1 dominated and suggest a predominant, but not exclusive, Th1 type of response.
Brozzetti A; Marzotti S; La Torre D; Bacosi ML; Morelli S; Bini V; Ambrosi B; Giordano R; Perniola R; De Bellis A; Betterle C; Falorni A;
Eur J Endocrinol; 2010 Aug; 163(2):309-17. PubMed ID: 20498138
[TBL] [Abstract][Full Text] [Related]
13. Estimated risk for developing autoimmune Addison's disease in patients with adrenal cortex autoantibodies.
Coco G; Dal Pra C; Presotto F; Albergoni MP; Canova C; Pedini B; Zanchetta R; Chen S; Furmaniak J; Rees Smith B; Mantero F; Betterle C
J Clin Endocrinol Metab; 2006 May; 91(5):1637-45. PubMed ID: 16522688
[TBL] [Abstract][Full Text] [Related]
14. Adrenal autoantibodies and organ-specific autoimmunity in patients with Addison's disease.
Söderbergh A; Winqvist O; Norheim I; Rorsman F; Husebye ES; Dolva O; Karlsson FA; Kämpe O
Clin Endocrinol (Oxf); 1996 Oct; 45(4):453-60. PubMed ID: 8959085
[TBL] [Abstract][Full Text] [Related]
15. Measuring adrenal autoantibody response: interlaboratory concordance in the first international serum exchange for the determination of 21-hydroxylase autoantibodies.
Falorni A; Chen S; Zanchetta R; Yu L; Tiberti C; Bacosi ML; Furmaniak J; Bini V; Dotta F; Eisenbarth GS; Smith BR; Betterle C
Clin Immunol; 2011 Sep; 140(3):291-9. PubMed ID: 21570358
[TBL] [Abstract][Full Text] [Related]
16. Addison's disease: a survey on 633 patients in Padova.
Betterle C; Scarpa R; Garelli S; Morlin L; Lazzarotto F; Presotto F; Coco G; Masiero S; Parolo A; Albergoni MP; Favero R; Barollo S; Salvà M; Basso D; Chen S; Rees Smith B; Furmaniak J; Mantero F
Eur J Endocrinol; 2013 Dec; 169(6):773-84. PubMed ID: 24014553
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison's disease.
Uibo R; Aavik E; Peterson P; Perheentupa J; Aranko S; Pelkonen R; Krohn KJ
J Clin Endocrinol Metab; 1994 Feb; 78(2):323-8. PubMed ID: 8106620
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune Addison's disease--evidence for a role of steroid 21-hydroxylase autoantibodies in adrenal insufficiency.
Furmaniak J; Kominami S; Asawa T; Wedlock N; Colls J; Smith BR
J Clin Endocrinol Metab; 1994 Nov; 79(5):1517-21. PubMed ID: 7962352
[TBL] [Abstract][Full Text] [Related]
19. [21-hydroxylase autoantibodies as a marker of adrenal involvement in patients with autoimmune endocrinopathies].
Degros V; Pons L; Ghulam A; Racadot A
Ann Biol Clin (Paris); 1999; 57(6):705-9. PubMed ID: 10572219
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune adrenocortical failure in Norway autoantibodies and human leukocyte antigen class II associations related to clinical features.
Myhre AG; Undlien DE; Løvås K; Uhlving S; Nedrebø BG; Fougner KJ; Trovik T; Sørheim JI; Husebye ES
J Clin Endocrinol Metab; 2002 Feb; 87(2):618-23. PubMed ID: 11836294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
